Adient posts Q1 adjusted net income of USD 28M, up 22%

Reuters
02/04
Adient posts Q1 adjusted net income of USD 28M, up 22%

Adient reported its first quarter (Q1) 2026 financial results, posting revenues of USD 3.64 billion, a 4% increase. The company recorded a Q1 GAAP net loss of USD 22 million, with diluted earnings per share $(EPS)$ at negative USD 0.28. On an adjusted basis, diluted EPS was USD 0.35, and adjusted EBITDA reached USD 207 million, up 6%. Adjusted EBITDA margin rose from 5.6 to 5.7 percentage points. At the end of December 2025, gross debt stood at USD 2.40 billion, net debt at USD 1.50 billion, and cash and cash equivalents at USD 855 million. Adient returned USD 25 million to shareholders in the quarter through the repurchase of approximately 1.2 million shares. The company raised its full year (FY) 2026 guidance, now expecting revenue of USD 14.60 billion, adjusted EBITDA of USD 880 million, and free cash flow of USD 125 million, citing improved vehicle production outlook and continued strong business performance. Capital expenditures are planned at USD 300 million for FY2026. Adient highlighted ongoing investments in innovation and automation, which are expected to support continued business momentum. The company operates approximately 200 manufacturing and assembly plants in 29 countries and serves all major original equipment manufacturers in the automotive seating market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adient plc published the original content used to generate this news brief on February 04, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10